The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease

Overview of attention for article published in Frontiers in endocrinology, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
twitter: 18 X users

facebook: 3 Facebook pages

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 68 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 21 X posts from 18 X users, with an upper bound of 31,116 followers.

RT @dreamgbutterfly: The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Mode…

12 Jul 2022

Reply Repost Favourite

📄 The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in... de @_ibima @cabimer @HRegionalMalaga depositado en ⬇️⬇️⬇️ https://t.co/sfQFNoEQNX #repositoriosalud #ProduccionCientificaSSPA

17 May 2022

Reply Repost Favourite

The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease https://t.co/RXDiX6Yxwp

26 Aug 2020

Reply Repost Favourite

Related Articles The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne). 2020;11:103 Authors: Romero-Zer…

28 Mar 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.